Boston An independent LDT provider
OBS:Immunovia har upphört med kommersialiseringen av IMMray PanCan-d-testet. Mer information finns här:

Diagnostic Landscape for Pancreatic Cancer

februari 17, 2021

Current Diagnostic Landscape for Pancreatic Cancer (PDAC)
Presenterad av Thomas C. King, MD, PhD, Medical Director

0:10 Routes of presentation for pancreatic cancer patients
0:59 The diagnostic processes (imaging and biopsy)
2:08 A blood biomarker test can improve these processes
2:26 Improvement for those with Vague symptoms
2:45 Improvements for High risk individuals
3:18 Improvements for Imaging abnormalities
3:37 Improvements for those with Worrisome symptoms
3:55 Diagnostic landscape: Imaging (Sensitivity, Specificity and Accuracy)
5:29 Diagnostic landscape: FNA (Sensitivity, Specificity and Accuracy)
6:38 Improving the diagnostic landscape with a blood based biomarker test
7:30 Summary